TrialScientific reports2025

Supplementation with short-chain fatty acids and a prebiotic improves clinical outcome in Parkinson's disease: a randomized double-blind prospective study.

Tobias Hegelmaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.